Literature DB >> 35291204

The current status of robotic surgery for endometrial cancer in Japan.

Tomoko Gota1, Kensuke Tomio1, Taichi Kurose1, Risa Saito1, Ryoken Nara1, Sohmi Kin1, Minami Hoshiba1, Yuri Ogata1, Misao Nakanishi1, Maya Takamoto1, Miyuki Sadatsuki1, Hajime Oishi1.   

Abstract

The da Vinci® surgical system (Intuitive Surgical Inc., Sunnyvale, CA, USA) was approved in 2009 by the Japanese Ministry of Health, Labor, and Welfare. In gynecology, robotic surgery for hysterectomy for benign indications and early-stage endometrial cancer has been covered by National Health Insurance since 2018. In a context where the da Vinci surgical system has prevailed in urology departments in Japan, gynecological robotic surgery has spread rapidly once it was covered by insurance. Although minimally invasive gynecologic surgery (minimally invasive surgery, or MIS) in Japan has a specific context, there are several problems with its safety, surgeon education, and cost in Japan. To maximize the many advantages of robotic surgery, its effectiveness needs to be carefully evaluated and this new technology needs to be safely incorporated in practice. 2022, National Center for Global Health and Medicine.

Entities:  

Keywords:  endometrial cancer; minimally invasive surgery; robotic surgery

Year:  2022        PMID: 35291204      PMCID: PMC8884040          DOI: 10.35772/ghm.2021.01077

Source DB:  PubMed          Journal:  Glob Health Med        ISSN: 2434-9186


  17 in total

Review 1.  Comparative safety and effectiveness of robot-assisted laparoscopic hysterectomy versus conventional laparoscopy and laparotomy for endometrial cancer: A systematic review and meta-analysis.

Authors:  D A Park; D H Lee; S W Kim; S H Lee
Journal:  Eur J Surg Oncol       Date:  2016-06-29       Impact factor: 4.424

2.  Early feasibility surveillance of gynecologic robotic-assisted surgeries in Japan.

Authors:  Tsukasa Baba; Masaki Mandai; Hirotaka Nishi; Osamu Nishii; Jo Kitawaki; Morio Sawada; Keiichi Isaka; Tomoyuki Fujii
Journal:  J Obstet Gynaecol Res       Date:  2019-01-20       Impact factor: 1.730

3.  Robotic-assisted vs traditional laparoscopic surgery for endometrial cancer: a randomized controlled trial.

Authors:  Minna M Mäenpää; Kari Nieminen; Eija I Tomás; Marita Laurila; Tiina H Luukkaala; Johanna U Mäenpää
Journal:  Am J Obstet Gynecol       Date:  2016-06-08       Impact factor: 8.661

4.  Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study.

Authors:  Joan L Walker; Marion R Piedmonte; Nick M Spirtos; Scott M Eisenkop; John B Schlaerth; Robert S Mannel; Richard Barakat; Michael L Pearl; Sudarshan K Sharma
Journal:  J Clin Oncol       Date:  2012-01-30       Impact factor: 44.544

5.  Comparison of laparoscopic surgery and conventional laparotomy for surgical staging of patients with presumed low-risk endometrial cancer: The current state of Japan.

Authors:  Imari Deura; Muneaki Shimada; Yukihiro Azuma; Hiroaki Komatsu; Kei Nagira; Mayumi Sawada; Tasuku Harada
Journal:  Taiwan J Obstet Gynecol       Date:  2019-01       Impact factor: 1.705

6.  Cost-effectiveness analysis of robotically assisted laparoscopy for newly diagnosed uterine cancers.

Authors:  Mario M Leitao; Aleksandra Bartashnik; Isaac Wagner; Stephen J Lee; Ari Caroline; William J Hoskins; Howard T Thaler; Nadeem R Abu-Rustum; Yukio Sonoda; Carol L Brown; Elizabeth L Jewell; Richard R Barakat; Ginger J Gardner
Journal:  Obstet Gynecol       Date:  2014-05       Impact factor: 7.661

7.  A comparative detail analysis of the learning curve and surgical outcome for robotic hysterectomy with lymphadenectomy versus laparoscopic hysterectomy with lymphadenectomy in treatment of endometrial cancer: a case-matched controlled study of the first one hundred twenty two patients.

Authors:  Peter C Lim; Elizabeth Kang; Do Hwan Park
Journal:  Gynecol Oncol       Date:  2010-12-30       Impact factor: 5.482

8.  Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic lymphadenectomy in women with high-risk endometrial cancer: A randomised controlled trial.

Authors:  Sahar Salehi; Elisabeth Åvall-Lundqvist; Berit Legerstam; Joseph W Carlson; Henrik Falconer
Journal:  Eur J Cancer       Date:  2017-04-29       Impact factor: 9.162

9.  Robotic-assisted versus conventional laparoscopic hysterectomy for endometrial cancer.

Authors:  Cherynne Yuin Mun Johansson; Felix Kwok Hee Chan
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2020-09-06

10.  Impact of Robotic Platforms on Surgical Approach and Costs in the Management of Morbidly Obese Patients with Newly Diagnosed Uterine Cancer.

Authors:  Mario M Leitao; Wazim R Narain; Donna Boccamazzo; Vasileios Sioulas; Danielle Cassella; Jennifer A Ducie; Ane Gerda Z Eriksson; Yukio Sonoda; Dennis S Chi; Carol L Brown; Douglas A Levine; Elizabeth L Jewell; Oliver Zivanovic; Richard R Barakat; Nadeem R Abu-Rustum; Ginger J Gardner
Journal:  Ann Surg Oncol       Date:  2016-01-07       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.